3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Motor Activity
5
Neoplasm Metastasis
3
Fatigue
3
Depression
3
Neoplasms
2
Lymphedema
2
Breast Cancer Lymphedema
2
Anxiety Disorders
2
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Neurotoxicity Syndromes
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Kinesiophobia
1
Head and Neck Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Bone Neoplasms
1
Body Weight Changes
1
Arthritis
1
Accessory Nerve Injuries
1
Interventions
Paclitaxel
5
Vincristine
3
Oxaliplatin
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
Amifostine
3
xaliproden
2
glucarpidase
2
Taxes
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Procarbazine
2
Methotrexate
2
Magnesium Sulfate
2
Leucovorin
2
Doxorubicin
2
Cyclophosphamide
2
Cisplatin
2
Calcium Gluconate
2
2,2'-dithiodiethanesulfonic acid
2
neurotropin
1
glutamic acid diethyl ester
1
eribulin
1
axicabtagene ciloleucel
1
Vitamin E
1
Trastuzumab
1
Thioctic Acid
1
Thalidomide
1
Tadalafil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neurotoxicity Syndromes
×
Exercise Therapy
×
Clear all
NCT04583124
2025-11-18
ATENTO
Universidad de Granada
Phase NA
Completed
42 enrolled